Myeloma Canada Scientific Roundtable

Created in 2009

Each year, the annual Myeloma Canada Scientific Roundtable brings together stakeholders, including Canada’s top myeloma experts from coast to coast, scientists from the USA and Europe, our industry research partners, and patients.

The meeting is an incubator for clinical trialResearch studies done with patients to evaluate new treatments or new ways of combining and administering existing treatments. By testing new drugs or combinations of drugs, each study is designed to find better ways to treat the disease, as well as improve quality of life and answer scientific and clinical questions. The overall goal of conducting clinical trials is to improve patient care and outcomes. ideas and supports our goal of developing high-impact made-in-Canada clinicalInvolving direct observation of a patient. trials for patients across the country.

The Myeloma Canada Scientific Roundtable is a hugely successful conference that, with each year, proves to be better than the last. The highly valuable presentations and topics spark important discussions, the sharing of ideas, and forward-thinking thought processes. All in all, the event invokes a positive sense of motivation and collaboration amongst all who attend.